Clinical Resarch
Within the clinical research department, all efforts are invested according to the most up-to-date standardized procedures (SOP) to deliver services of feasibility of research project, protocols elaboration, submission to regulatory authorities, implementation, monitoring, validation and coordination of clinical biology services, pharmacovigilance monitoring , reporting and reconciliation of events , IMPs management , data verification and storage ; site closures and medical writing of end of study reports.
read more
Biomarkers, Central Lab and Clinical biology services & QA
Biomarkers nowadays are largely applied to drug development in a number of distinct ways. First, they may be applied as additional diagnostic measures in a population clinically identified as having the disease. Sensitivity, specificity, and positive predictive value all must be considered for such an application.One of the most important uses of biomarkers in drug development is as an indirect measure of disease severity. A number of points should be established for such use: the marker must have a scientific rationale , it should change with disease progression in longitudinal observational studies, and must be measurable and reproducible.
read more
Data Management
Our CDMS is adaptative to both methodology used , paper data collection or electronic data collection. Our data validation process is comprehensive and robust .Minimal requirements for data management should be regarded as the starting level to be able to participate in common trial activities . In this sense, minimal requirements identify the level of minimum quality standards that could be assured to external partners wishing to make use of the abilities of Poseidon CRO . This level is defined clearly and explicitly, so that system audits can be performed easily ...
read more
About us
Poseidon CRO is a full services CRO operating in the fields of Human pharmaceuticals, biotechnology, Nutrition, Cosmetics, Medical devices and Veterenary care and nutrition. Our good knowledge of the distribution among prestigious sites of high caliber investigators comitted to accurate and valuable contribution in clinical studies, is our strong asset. Beyond this, in Tunisia , regulation is focused on patient's interests in participating to trial and thus getting advantages and care they may not afford to reach otherwise...
read more